Flamand V - Search Results

1

Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.

Zhao H, Flamand V, Peehl DM. Zhao H, et al. Among authors: flamand v. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55. BMC Med Genomics. 2009. PMID: 19691856 Free PMC article.

2

Targeting monoamine oxidase A in advanced prostate cancer.

Flamand V, Zhao H, Peehl DM. Flamand V, et al. J Cancer Res Clin Oncol. 2010 Nov;136(11):1761-71. doi: 10.1007/s00432-010-0835-6. Epub 2010 Mar 4. J Cancer Res Clin Oncol. 2010. PMID: 20204405 Free PMC article.

3

Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature.

Ploussard G, Almeras C, Briganti A, Giannarini G, Hennequin C, Ost P, Renard-Penna R, Salin A, Lebret T, Villers A, Soulié M, de la Taille A, Flamand V. Ploussard G, et al. Among authors: flamand v. J Urol. 2015 Oct;194(4):983-8. doi: 10.1016/j.juro.2015.04.103. Epub 2015 May 9. J Urol. 2015. PMID: 25963190 Review.

4

What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?

Lebdai S, Basset V, Branchereau J, de La Taille A, Flamand V, Lebret T, Murez T, Neuzillet Y, Ploussard G, Audenet F. Lebdai S, et al. Among authors: flamand v. World J Urol. 2016 May;34(5):617-24. doi: 10.1007/s00345-015-1687-0. Epub 2015 Sep 15. World J Urol. 2016. PMID: 26373956 Review.

5

Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.

Rouprêt M, Drouin SJ, Larré S, Neuzillet Y, Botto H, Hitier M, Rigaud J, Crew J, Xylinas E, Salomon L, Cornu JN, Iborra F, Champetier D, Rozet F, Flamand V, Bastide C, Cormier L, Durand X, Lunardi P, Rischmann P, Nouhaud FX, Ferlicot S, Patard JJ, Floch AP, Irani J, Peyronnet B, Bensalah K, Poissonnier L, Grès P, Droupy S, Casenave J, Wallerand H, Soulié M, Pfister C; Bladder Cancer Committee of the French National Association of Urology (“CC-AFU Vessie”). Rouprêt M, et al. Among authors: flamand v. Ann Surg Oncol. 2011 Dec;18(13):3833-8. doi: 10.1245/s10434-011-1824-y. Epub 2011 Jun 7. Ann Surg Oncol. 2011. PMID: 21647762

6

Robot-assisted partial prostatectomy for anterior prostate cancer: a step-by-step guide.

Villers A, Flamand V, Arquímedes RC, Puech P, Haber GP, Desai MM, Crouzet S, Ouzzane A, Gill IS. Villers A, et al. Among authors: flamand v. BJU Int. 2017 Jun;119(6):968-974. doi: 10.1111/bju.13785. Epub 2017 Feb 26. BJU Int. 2017. PMID: 28111893 Free PMC article. Clinical Trial.

7

Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes.

Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M, Patard JJ, Méjean A, Bensalah K; members of the Kidney Cancer group of the CCAFU. Bigot P, et al. Among authors: flamand v. Urol Oncol. 2017 Jan;35(1):35.e15-35.e19. doi: 10.1016/j.urolonc.2016.08.012. Epub 2016 Sep 28. Urol Oncol. 2017. PMID: 27692834 Free PMC article.

8

Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.

Villers A, Puech P, Flamand V, Haber GP, Desai MM, Crouzet S, Leroy X, Chopra S, Lemaitre L, Ouzzane A, Gill IS. Villers A, et al. Among authors: flamand v. Eur Urol. 2017 Sep;72(3):333-342. doi: 10.1016/j.eururo.2016.08.057. Epub 2016 Sep 6. Eur Urol. 2017. PMID: 27613061 Free PMC article.

9

A novel robotic system for single-port urologic surgery: first clinical investigation.

Kaouk JH, Haber GP, Autorino R, Crouzet S, Ouzzane A, Flamand V, Villers A. Kaouk JH, et al. Among authors: flamand v. Eur Urol. 2014 Dec;66(6):1033-43. doi: 10.1016/j.eururo.2014.06.039. Epub 2014 Jul 17. Eur Urol. 2014. PMID: 25041850 Clinical Trial.

10

[Choice of new drugs in castration-resistant prostate cancer: predictive factors and effectiveness assessment].

Basset V, Flamand V, Crouzet S, Ploussard G. Basset V, et al. Among authors: flamand v. Prog Urol. 2013 Oct;23 Suppl 1:S44-8. doi: 10.1016/S1166-7087(13)70045-9. Prog Urol. 2013. PMID: 24314738 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page